The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Open accessAbstract
“K2” and “Spice” drugs (collectively hereafter referred to as Spice) represent a relatively new class of designer drugs that have recently emerged as popular alternatives to marijuana, otherwise characterized as “legal highs”. These drugs are readily available on the Internet and sold in many head shops and convenience stores under the disguise of innocuous products like herbal blends, incense, or air fresheners. Although package labels indicate “not for human consumption”, the number of intoxicated people presenting to emergency departments is dramatically increasing. The lack of validated and standardized human testing procedures and an endless supply of potential drugs of abuse are primary reasons why researchers find it difficult to fully characterize clinical consequences associated with Spice. While the exact chemical composition and toxicology of Spice remains to be determined, there is mounting evidence identifying several synthetic cannabinoids as causative agents responsible for psychoactive and adverse physical effects. This review provides updates of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances. The pharmacological and toxicological consequences of synthetic cannabinoid abuse are also reviewed to provide a future perspective on potential short- and long-term implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203 · cited 1×
“The hippocampus and the amygdala are brain regions involved, respectively, in memory and the pathophysiology of schizophrenia (Tamminga et al., 2010) and emotion processing (Phelps and LeDoux, 2005).”
BackgroundPertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 812
‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1558 · Cited by 660
Abnormal gray and white matter volume in delusional infestation
Wolf, R. C., Huber, M., Depping, M. S., Thomann, P. A., Karner, M., Lepping, P., & Freudenmann, R. W. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.004 · Cited by 606
The Hippocampal Formation in Schizophrenia
Tamminga, C. A., Stan, A. D., & Wagner, A. D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09081187 · Cited by 582
Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain
ONAIVI, E. S., ISHIGURO, H., GONG, J., PATEL, S., PERCHUK, A., MEOZZI, P. A., MYERS, L., MORA, Z., TAGLIAFERRO, P., GARDNER, E., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.052 · Cited by 543
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use
Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., & Lubman, D. I. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.6.694 · Cited by 497
Beyond THC: The New Generation of Cannabinoid Designer Drugs
Fattore, L., & Fratta, W. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00060 · Cited by 443
Self-citationBrain cannabinoid CB2 receptors modulate cocaine's actions in mice
Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., Yang, H.-J., Bi, G.-H., Li, J., & Gardner, E. L. (2011) · Nature Neuroscience · doi:10.1038/nn.2874 · Cited by 397
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Fernández-Ruiz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362
Spice drugs as a new trend: Mode of action, identification and legislation
Vardakou, I., Pistos, C., & Spiliopoulou, C. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.06.002 · Cited by 341
Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., & Auwärter, V. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1811 · Cited by 309
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Every-Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 299
Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009) · Forensic Science International · doi:10.1016/j.forsciint.2009.06.008 · Cited by 299
Cannabis and psychosis/schizophrenia: human studies
D’Souza, D. C., Sewell, R. A., & Ranganathan, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0024-2 · Cited by 295
D'Ambra, T. E., Estep, K. G., Bell, M. R., Eissenstat, M. A., Josef, K. A., Ward, S. J., Haycock, D. A., Baizman, E. R., & Casiano, F. M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a016 · Cited by 294
A survey study to characterize use of Spice products (synthetic cannabinoids)
Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.011 · Cited by 283
Withdrawal Phenomena and Dependence Syndrome After the Consumption of „Spice Gold“
Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0464 · Cited by 278
McGrath, J., Welham, J., Scott, J., Varghese, D., Degenhardt, L., Hayatbakhsh, M. R., Alati, R., Williams, G. M., Bor, W., & Najman, J. M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.6 · Cited by 276
Design, Synthesis and Pharmacology of Cannabimimetic Indoles
Huffman, J. W., Dai, D., Martin, B. R., & Compton, D. R. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80155-4 · Cited by 275
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Mir, A., Obafemi, A., Young, A., & Kane, C. (2011) · Pediatrics · doi:10.1542/peds.2010-3823 · Cited by 266
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M., & Nagarkatti, P. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.04.001 · Cited by 263
Atwood, B. K., Huffman, J., Straiker, A., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00582.x · Cited by 262
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects
Onaivi, E. S., Ishiguro, H., Gong, J.-P., Patel, S., Meozzi, P. A., Myers, L., Perchuk, A., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001640 · Cited by 257
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.01.004 · Cited by 245
Di Marzo, V., De Petrocellis, L., Fezza, F., Ligresti, A., & Bisogno, T. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0349 · Cited by 242
Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids
Wiley, J. L., Compton, D. R., Dai, D., Lainton, J. A. H., Phillips, M., Huffman, J. W., & Martin, B. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37496-8 · Cited by 240
Pistis, M., Ferraro, L., Pira, L., Flore, G., Tanganelli, S., Gessa, G. L., & Devoto, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03055-x · Cited by 227
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Qamri, Z., Preet, A., Nasser, M. W., Bass, C. E., Leone, G., Barsky, S. H., & Ganju, R. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0448 · Cited by 224
Detection of JWH-018 metabolites in smoking mixture post-administration urine
Sobolevsky, T. G., Prasolov, I., & Rodchenkov, G. M. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.04.003 · Cited by 219
Teske, J., Weller, J.-P., Fieguth, A., et al. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.03.016 · Cited by 216
“Spice” Girls: Synthetic Cannabinoid Intoxication
Schneir, A. B., Cullen, J., & Ly, B. T. (2011) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2010.10.014 · Cited by 215
Brents, L. K., Reichard, E. E., Zimmerman, S. M., Moran, J. H., Fantegrossi, W. E., & Prather, P. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021917 · Cited by 214
Self-citationSevere Toxicity Following Synthetic Cannabinoid Ingestion
Lapoint, J., James, L. P., Moran, C. L., Nelson, L. S., Hoffman, R. S., & Moran, J. H. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.609822 · Cited by 212
Self-citationMüller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J.-M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.001 · Cited by 183
Onaivi, E. S., Ishiguro, H., Gong, J., Patel, S., Meozzi, P. A., Myers, L., Perchuk, A., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.036 · Cited by 178
Hojo, M., Sudo, Y., Ando, Y., Minami, K., Takada, M., Matsubara, T., Kanaide, M., Taniyama, K., Sumikawa, K., & Uezono, Y. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08244fp · Cited by 173
Hillebrand, J., Olszewski, D., & Sedefov, R. (2010) · Substance Use & Misuse · doi:10.3109/10826080903443628 · Cited by 172
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
Marzo, V. D., & Petrocellis, L. D. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 169
Endocannabinoid system dysfunction in mood and related disorders
Ashton, C. H., & Moore, P. B. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01687.x · Cited by 163
Allosteric modulation of heterodimeric G-protein-coupled receptors
Milligan, G., & Smith, N. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.001 · Cited by 162
Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series
Hurst, D., Loeffler, G. H., & McLay, R. N. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010176 · Cited by 156
Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwärter, V. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1877 · Cited by 155
Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?
Seely, K. A., Prather, P. L., James, L. P., & Moran, J. H. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.6 · Cited by 153
Self-citationAminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics
Eissenstat, M. A., Bell, M. R., D'Ambra, T. E., Alexander, E. J., Daum, S. J., Ackerman, J. H., Gruett, M. D., Kumar, V., & Estep, K. G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a013 · Cited by 153
Brents, L. K., Gallus‐Zawada, A. E., Radominska-p, A., Vasiljevik, T., Prisinzano, T. E., Fantegrossi, W. E., Moran, J. H., & Prather, P. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.004 · Cited by 149
Self-citationDesigner drugs: a medicinal chemistry perspective
Carroll, F. I., Lewin, A. H., Mascarella, S. W., Seltzman, H. H., & Reddy, P. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06199.x · Cited by 149
The emergence and analysis of synthetic cannabinoids
Hudson, S. C., & Ramsey, J. M. (2011) · Drug Testing and Analysis · doi:10.1002/dta.268 · Cited by 145
Solinas, M., Panlilio, L. V., Justinová, Z., Yaşar, S., & Goldberg, S. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.167 · Cited by 143
College students and use of K2: an emerging drug of abuse in young persons
Hu, X., Primack, B. A., Barnett, T. E., et al. (2011) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-6-16 · Cited by 140
Lombard, C. A., Nagarkatti, M., & Nagarkatti, P. S. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.11.002 · Cited by 136
Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication
Balster, R. L., & Prescott, W. R. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80051-x · Cited by 133
Grigoryev, A., Savchuk, S. A., Melnik, A., et al. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.03.034 · Cited by 132
Synthetic Cannabinoid Use: A Case Series of Adolescents
Castellanos, D., Singh, S., Thornton, G. M., et al. (2011) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2011.08.002 · Cited by 129
Screening for the synthetic cannabinoid JWH‐018 and its major metabolites in human doping controls
Möller, I., Wintermeyer, A., Mercer‐Chalmers‐Bender, K., et al. (2010) · Drug Testing and Analysis · doi:10.1002/dta.158 · Cited by 128
Hudson, S. C., Ramsey, J., King, L. A., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010) · Journal of Analytical Toxicology · doi:10.1093/jat/34.5.252 · Cited by 124
Uchiyama, N., Kawamura, M., Kikura‐Hanajiri, R., & Goda, Y. (2010) · Forensic Toxicology · doi:10.1007/s11419-010-0100-3 · Cited by 122
Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats
Wiley, J. L., Barrett, R. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00027-4 · Cited by 122
Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation
Young, A. C., Schwarz, E. S., Medina, G., Obafemi, A. I., Feng, S., Kane, C., & Kleinschmidt, K. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.05.013 · Cited by 121
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition
Hájos, N., & Freund, T. F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00149-4 · Cited by 121
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Ghosh, S. T., Preet, A., Groopman, J. E., & Ganju, R. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.01.005 · Cited by 120
Convulsions Associated with the Use of a Synthetic Cannabinoid Product
Schneir, A., & Baumbacher, T. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0182-2 · Cited by 119
Three cases of “spice” exposure
Simmons, J. R., Cookman, L., Kang, C., et al. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.584316 · Cited by 118
Akirav, I. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00034 · Cited by 117
Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Hudson, B. D., Hébert, T. E., & Kelly, M. E. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060251 · Cited by 112
Synthetic Cannabinoids in Oral Fluid
Coulter, C., Garnier, M., & Moore, C. M. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.7.424 · Cited by 105
Huffman, J. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054368844 · Cited by 103
Comparison of “herbal highs” composition
Zuba, D., Byrska, B., & Maciów, M. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4743-7 · Cited by 101
Drugs on the web; the Psychonaut 2002 EU project
Schifano, F., Deluca, P., Baldacchino, A., Peltoniemi, T., Scherbaum, N., Torrens, M., Farré, M., Flores, I., Rossi, M., Eastwood, D., et al. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.035 · Cited by 101
Wells, D. L., & Ott, C. A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p580 · Cited by 100
Every‐Palmer, S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03119.x · Cited by 99
Nasser, M. W., Qamri, Z., Deol, Y. S., Smith, D. L., Shilo, K., Zou, X., & Ganju, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023901 · Cited by 99
Olea‐Herrero, N., Vara‐Ciruelos, D., Malagarie‐Cazenave, S., & Díaz‐Laviada, I. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605248 · Cited by 98
Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment
Hill, M. N., Sun, J. C., Tse, M., & Gorzalka, B. B. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005651 · Cited by 98
Chimalakonda, K. C., Moran, C. L., Kennedy, P. D., et al. (2011) · Analytical Chemistry · doi:10.1021/ac201377m · Cited by 96
Intoxication From Smoking “Spice”
Simmons, J. R., Skinner, C. G., Williams, J., et al. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.08.039 · Cited by 95
Synthetic Cannabinoid Exposures Reported to Texas Poison Centers
Forrester, M. B., Kleinschmidt, K., Schwarz, E. S., & Young, A. (2011) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.609807 · Cited by 95
Inhibition of monoamine oxidase activity by cannabinoids
Fišar, Z. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0517-6 · Cited by 88
Ferraro, L., Tomasini, M. C., Gessa, G. L., Bebe, B. W., Tanganelli, S., & Antonelli, T. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.8.728 · Cited by 86
Chimalakonda, K. C., Bratton, S. M., Le, V.-H., Yiew, K. H., Dineva, A., Moran, C. L., James, L. P., Moran, J. H., & Radominska-p, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040709 · Cited by 84
Self-citationA preliminary investigation on the distribution of cannabinoids in man
Gronewold, A., & Skopp, G. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.04.010 · Cited by 81
1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice
Wiley, J. L., Marusich, J. A., Martin, B. R., & Huffman, J. W. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.11.001 · Cited by 80
Grigoryev, A., Melnik, A., Savchuk, S. A., et al. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.07.004 · Cited by 79
Jankovics, P., Váradi, A., Tölgyesi, L., et al. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.07.011 · Cited by 78
Huffman, J. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-503-9_3 · Cited by 71
Pharmacological specificity of Δ9-tetrahydrocannabinol discrimination in rats
Barrett, R. L., Wiley, J. L., Balster, R. L., et al. (1995) · Psychopharmacology · doi:10.1007/bf02245942 · Cited by 68
Engeli, S. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_17 · Cited by 66
ElSohly, M. A., Gul, W., ElSohly, K. M., et al. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.7.487 · Cited by 63
Uchiyama, N., Kikura‐Hanajiri, R., & Goda, Y. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.1203 · Cited by 62
“Legal Highs” – New Players in the Old Drama
Zawilska, J. B. (2011) · Current Drug Abuse Reviews · doi:10.2174/1874473711104020122 · Cited by 61
Opioids and Cannabinoids Interactions: Involvement in Pain Management
Desroches, J., & Beaulieu, P. (2010) · Current Drug Targets · doi:10.2174/138945010790980303 · Cited by 57
Nakajima, J., Takahashi, M., Seto, T., & Suzuki, J. (2010) · Forensic Toxicology · doi:10.1007/s11419-010-0101-2 · Cited by 56
Acute inferior myocardial infarction due to cannabis smoking in a young man
Kocabay, G., Yildiz, M., Duran, N. E., & Özkan, M. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32832bcfbe · Cited by 54
Discriminative stimulus properties of Δ9-tetrahydrocannabinol (THC) in C57Bl/6J mice
Vann, R. E., Warner, J. A., Bushell, K. N., Huffman, J. W., Martin, B. R., & Wiley, J. L. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.010 · Cited by 50
Cannabinoid receptor agonist WIN 55,212‐2 inhibits rat cortical dialysate γ‐aminobutyric acid levels
Ferraro, L., Tomasini, M. C., Cassano, T., Bebe, B. W., Siniscalchi, A., O'Connor, W. T., Magee, P. J., Tanganelli, S., Cuomo, V., & Antonelli, T. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1224 · Cited by 48
Identification of 1-butyl-3-(1-(4-methyl)naphthoyl)indole in a herbal mixture
Westphal, F., Sönnichsen, F. D., & Thiemt, S. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.03.031 · Cited by 44
Tomiyama, K., & Funada, M. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.08.021 · Cited by 43
Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists
Gerra, G., Zaimovic, A., Gerra, M. L., Ciccocioppo, R., Cippitelli, A., Serpelloni, G., & Somaini, L. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910789753521 · Cited by 40
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase
Fišar, Z. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.010 · Cited by 28
Ho, B. Y., & Zhao, J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12792-0 · Cited by 20
Protein PTMs: post‐translational modifications or pesky trouble makers?
Bradshaw, R. A., Medzihradszky, K. F., & Chalkley, R. J. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1786 · Cited by 17
Homology Modeling of Cannabinoid Receptors: Discovery of Cannabinoid Analogues for Therapeutic Use
Chang, C. A., Ai, R., Gutierrez, M., & Marsella, M. J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-465-0_35 · Cited by 12
Cited by
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2015.1110590 · Cited by 378
Murray, R. M., Quigley, H., Quattrone, D., Englund, A., & Di Forti, M. (2016) · World Psychiatry · doi:10.1002/wps.20341 · Cited by 315
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Radhakrishnan, R., Wilkinson, S. T., & D’Souza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 310
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 296
Metadata
- Authors
- Seely, K. A., Lapoint, J., Moran, J. H., & Fattore, L.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 39
- Issue
- 2
- Pages
- 234-243
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2110036909
- Cited by
- 465
- References
- 106
- FWCI
- 62.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.